Sotalol Controlled-Release Systems for Arrhythmias: In Vitro Characterization, in Vivo Drug Disposition, and Electrophysiologic Effects
- 1 February 1994
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 83 (2) , 156-164
- https://doi.org/10.1002/jps.2600830209
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The efficacy of controlled release D-sotalol-polyurethane epicardial implants for ventricular arrhythmias due to acute ischemia in dogsJournal of Controlled Release, 1993
- Efficacy of Epicardial Controlled-Release Lidocaine for Ventricular Tachycardia Induced by Rapid Ventricular Pacing in DogsJournal of Cardiovascular Pharmacology, 1990
- Conversion of Ouabain-Induced Ventricular Tachycardia in Dogs with Epicardial Lidocaine: Pharmacodynamics and Functional EffectsPharmaceutical Research, 1990
- Cardiac controlled release for arrhythmia therapy: Lidocaine-polyurethane matrix studiesJournal of Controlled Release, 1988
- The Porous Titanium Steroid Eluting Electrode: A Double Blind Study Assessing the Stimulation Threshold Effects of SteroidPacing and Clinical Electrophysiology, 1988
- Controlled-Release Drug Delivery of Diphosphonates to Inhibit Bioprosthetic Heart Valve Calcification: Release Rate Modulation with Silicone Matrices Via Drug Solubility and Membrane CoatingJournal of Pharmaceutical Sciences, 1987
- Controlled release of diphosphonate to inhibit bioprosthetic heart valve calcification: Dose-response and mechanistic studiesJournal of Controlled Release, 1986
- Inhibition of Calcification of Bioprosthetic Heart Valves by Local Controlled-Release DiphosphonateScience, 1985
- SUSTAINED RELEASE OF GENTAMICIN FROM PROSTHETIC HEART VALVESAsaio Journal, 1979
- A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474British Journal of Pharmacology, 1970